[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @SanofiUS Sanofi US Sanofi US posts on X about $7846t the most. They currently have XXXXXX followers and X posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::183033795/interactions)  - X Week XXX +1,251% - X Month XXXXX -XX% - X Months XXXXX +162% - X Year XXXXXX -XXX% ### Mentions: X [#](/creator/twitter::183033795/posts_active)  - X Week X +300% - X Month X +14% - X Months XX +31% - X Year XX +67% ### Followers: XXXXXX [#](/creator/twitter::183033795/followers)  - X Week XXXXXX +0% - X Month XXXXXX -XXXX% - X Months XXXXXX -XXXX% - X Year XXXXXX -XXXX% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::183033795/influencer_rank)  ### Social Influence [#](/creator/twitter::183033795/influence) --- **Social category influence** [stocks](/list/stocks) XX% **Social topic influence** [$7846t](/topic/$7846t) XX% **Top accounts mentioned or mentioned by** [@wethenorth47](/creator/undefined) [@usfda](/creator/undefined) [@oranomed](/creator/undefined) [@radiomedix](/creator/undefined) [@raredisease_adv](/creator/undefined) [@necouncil](/creator/undefined) [@hinj_org](/creator/undefined) [@alisagev](/creator/undefined) [@drdevikaa](/creator/undefined) [@lungassociation](/creator/undefined) [@cryptoseedz](/creator/undefined) [@istplifescience](/creator/undefined) [@nowits1984](/creator/undefined) [@biff234523](/creator/undefined) ### Top Social Posts [#](/creator/twitter::183033795/posts) --- Top posts by engagements in the last XX hours "#NEWS: The @US_FDA accepted the filing of our sBLA for recently diagnosed stage X #Type1Diabetes for expedited review through the FDA Commissioners National Priority Voucher (CNPV) pilot program. Learn more" [X Link](https://x.com/SanofiUS/status/1980238131082436899) [@SanofiUS](/creator/x/SanofiUS) 2025-10-20T11:42Z 80.3K followers, XXX engagements "We have presented phase X data at #ESMO25 supporting the potential of our investigational therapy for gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Learn more CC: @OranoMed @RadioMedix" [X Link](https://x.com/SanofiUS/status/1980262983940067410) [@SanofiUS](/creator/x/SanofiUS) 2025-10-20T13:21Z 80.3K followers, XXX engagements "Results from a phase X study evaluating an investigational treatment for alpha-1 antitrypsin deficiency (#AATD) achieved all primary and key secondary endpoints. Read our press release to learn more about our research on this #RareDisease" [X Link](https://x.com/SanofiUS/status/1980984694406857144) [@SanofiUS](/creator/x/SanofiUS) 2025-10-22T13:08Z 80.3K followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Sanofi US posts on X about $7846t the most. They currently have XXXXXX followers and X posts still getting attention that total XXX engagements in the last XX hours.
Social category influence stocks XX%
Social topic influence $7846t XX%
Top accounts mentioned or mentioned by @wethenorth47 @usfda @oranomed @radiomedix @raredisease_adv @necouncil @hinj_org @alisagev @drdevikaa @lungassociation @cryptoseedz @istplifescience @nowits1984 @biff234523
Top posts by engagements in the last XX hours
"#NEWS: The @US_FDA accepted the filing of our sBLA for recently diagnosed stage X #Type1Diabetes for expedited review through the FDA Commissioners National Priority Voucher (CNPV) pilot program. Learn more"
X Link @SanofiUS 2025-10-20T11:42Z 80.3K followers, XXX engagements
"We have presented phase X data at #ESMO25 supporting the potential of our investigational therapy for gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Learn more CC: @OranoMed @RadioMedix"
X Link @SanofiUS 2025-10-20T13:21Z 80.3K followers, XXX engagements
"Results from a phase X study evaluating an investigational treatment for alpha-1 antitrypsin deficiency (#AATD) achieved all primary and key secondary endpoints. Read our press release to learn more about our research on this #RareDisease"
X Link @SanofiUS 2025-10-22T13:08Z 80.3K followers, XXX engagements
/creator/x::SanofiUS